Cargando…

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

Detalles Bibliográficos
Autores principales:	Overbeek, J.K., Heine, R. ter, Verheul, H.M.W., Chatelut, E., Rudek, M.A., Gurney, H., Plummer, R., Gilbert, D.C., Buclin, T., Burger, D.M., Bloemendal, H.J., van Erp, N.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813708/ https://www.ncbi.nlm.nih.gov/pubmed/36603522 http://dx.doi.org/10.1016/j.esmoop.2022.100749

Ejemplares similares

Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study
por: de Jong, Loek A. W., et al.
Publicado: (2020)

Correction to: Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin‑based HIPEC: results of the GUTOX study
por: de Jong, Loek A. W., et al.
Publicado: (2022)

Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer
por: Janssen, A, et al.
Publicado: (2017)

The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Anticancer Evaluation of Adiantum venustum Don
por: Viral, D, et al.
Publicado: (2011)

High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors
por: Gerritse, Sophie L., et al.
Publicado: (2022)

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients
por: van Erp, Nielka P., et al.
Publicado: (2016)

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents
por: Chatelut, E, et al.
Publicado: (2012)

The spliceosome as target for anticancer treatment
por: van Alphen, R J, et al.
Publicado: (2009)

Characterization of biological responses of colorectal cancer cells to anticancer regimens
por: Roh, Seon Ae, et al.
Publicado: (2012)

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
por: van Leeuwen, R W F, et al.
Publicado: (2013)

Prevalence of the Minimally Conscious State Among Institutionalized Patients in the Netherlands: A Nationwide Study
por: Overbeek, Berno U.H., et al.
Publicado: (2023)

The relationship between stigmatisation and quality of life in Ghanaian women and men with fertility problems: mediating role of coping strategies
por: Van Rooij, FB, et al.
Publicado: (2021)

Preventive regimen of immunostimulants within personalised “3S” paradigm of anticancer drug testing
por: Moiseeva, Ekaterina
Publicado: (2014)

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
por: Veal, Gareth J., et al.
Publicado: (2016)

Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
por: de Joode, K., et al.
Publicado: (2020)

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
por: de Jong, Loek A. W., et al.
Publicado: (2023)

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
por: Schuurhuizen, Claudia SEW, et al.
Publicado: (2018)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
por: Hoek, Jantien, et al.
Publicado: (2016)

Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning
por: Wolf, Dominik, et al.
Publicado: (2014)

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
por: Mammatas, L. H., et al.
Publicado: (2020)

The Effect of Non-penicillin Antibiotic Regimens on Neonatal Outcomes in Preterm Premature Rupture of Membranes
por: Siegel, Anne M., et al.
Publicado: (2019)

Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients
por: Kannan, M., et al.
Publicado: (2022)

Group theory in quantum mechanics: an introduction to its present usage
por: Heine, Volker, et al.
Publicado: (1960)

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
por: Zhang, F., et al.
Publicado: (2016)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
por: Li, Xuanyi, et al.
Publicado: (2022)

Efficacy of traditional treatment regimen on Kati Shoola with special reference to lumbar spondylolisthesis
por: Ediriweera, E. R. H. S. S., et al.
Publicado: (2013)

Survival of a Foal with Type A Botulism
por: Prutton, J.S.W., et al.
Publicado: (2016)

A comparison of sequential total and activated white cell count in patients undergoing coronary artery bypass grafting, using cardiopulmonary bypass, with and without a white cell filter
por: Nanson, JK, et al.
Publicado: (1999)

Anticancer, Anticoagulant, Antioxidant and Antimicrobial Activities of Thevetia peruviana Latex with Molecular Docking of Antimicrobial and Anticancer Activities
por: Al-Rajhi, Aisha M. H., et al.
Publicado: (2022)

Synergistic anticancer effect of curcumin and chemotherapy regimen FP in human gastric cancer MGC-803 cells
por: He, Bin, et al.
Publicado: (2017)

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic
por: Stroh, M, et al.
Publicado: (2014)

Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
por: Cross, Jasmine M., et al.
Publicado: (2020)

The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients
por: Schijvens, Anne M., et al.
Publicado: (2018)

Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens
por: Stockmann, C, et al.
Publicado: (2015)

Editorial: Anticancer Potential of Artemisia annua
por: Kolesar, Jill M., et al.
Publicado: (2022)

Identification of Potential Anticancer Activities of Novel Ganoderma lucidum Extracts Using Gene Expression and Pathway Network Analysis
por: Kao, Chi H.J., et al.
Publicado: (2016)

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ridjndc9v5tmeg8omhegpvuotb